Financial Services » Financial Services » Venture capital worldwide | Top medical technology venture financing deals global 2017

Value of top ten medtech venture financing deals globally 2017

Value of top 10 medical technology venture financing rounds worldwide in 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)
Created with Highcharts 5.0.1490090080080036036010510576.576.57474707058.558.552525050Grail (Series B)Verily Life Sciences (Seed capital)Guardant Health (Series E)Annoroad (Undisclosed)Outset Medical (Series C)Neuropace (Undisclosed)Electrocore (Series B)Respicardia (Series F)Color Genomics (Series C)Moximed (Series C)050100150200250300350400450500550600650700750800850900950

The data illustrates the value the top 10 medical technology venture financing rounds worldwide in 2017. In that year, Grail had a Series B venture round valued at 900 million USD.

Grail (Series B) 900
Verily Life Sciences (Seed capital) 800
Guardant Health (Series E) 360
Annoroad (Undisclosed) 105
Outset Medical (Series C) 76.5
Neuropace (Undisclosed) 74
Electrocore (Series B) 70
Respicardia (Series F) 58.5
Color Genomics (Series C) 52
Moximed (Series C) 50

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.